National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

From the 1/7/2022 release of VAERS data:

Found 4,662 cases where Vaccine is HEPA or HEPAB or HEPATYP and Serious

Government Disclaimer on use of this data



Case Details

This is page 15 out of 467

Result pages: prev   6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24   next


VAERS ID: 176475 (history)  
Form: Version 1.0  
Age: 51.0  
Sex: Male  
Location: Massachusetts  
Vaccinated:2001-08-31
Onset:2001-09-28
   Days after vaccination:28
Submitted: 2001-10-16
   Days after onset:18
Entered: 2001-10-19
   Days after submission:3
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEP: HEP B (ENGERIX-B) / SMITHKLINE BEECHAM 5212C6 / 1 - / IM
HEPA: HEP A (HAVRIX) / SMITHKLINE BEECHAM 698D6 / 3 - / IM

Administered by: Public       Purchased by: Other
Symptoms: Disturbance in attention, Dizziness, Fatigue, HIV infection, Lymphadenopathy, Optic neuritis, Red blood cell sedimentation rate increased, Scotoma, Vision blurred, Visual field defect
SMQs:, Anticholinergic syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Glaucoma (broad), Optic nerve disorders (narrow), Demyelination (narrow), Lens disorders (broad), Retinal disorders (broad), Depression (excl suicide and self injury) (broad), Vestibular disorders (broad), Ocular infections (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 5 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: atorvastatin (Lipitor) 20mg daily; testosterone gel (Androgel)
Current Illness: NONE
Preexisting Conditions: HIV since 1987; hypercholesterolemia; hypogonadism; allergy to sulfamethoxazole/trimethoprim (fever). He experienced "generalized wasting as a medication side effect" while taking "four NRTIs plus efavirens" to treat the HIV. Surgical: appendectomy
Allergies:
Diagnostic Lab Data: 6/15/01-serologies for Hep-A, Hep-B surface antigens and Hep-C were neg; 8/31/01-CD4 cell county was 570 cells/cu mm and viral load was 72,000 copies/mL; Visual fields-left sided monocular scotoma in the inferior part, diffusely blurred disk margins in both pupils; "modest" lymphadenopathy bilaterally in the neck; "Initially ESR-"mildly" elevated at 47mm/hr, repeat-21mm/hr; LP-"notable" CSF opening pressure 19mmH20 and protein of 47mg/dL; CSF glucose-57mg/dL; Cytology-neg for malignant cells; Blood and urine cx-neg; Hep-A serostatus 10/5/01-(+), Hep-B surface antigen-neg; MRA and MRI of head showed "no vascular changes"; MRI of orbits-nml
CDC Split Type: 20010237502

Write-up: On an unspecified date, the pt received injections of Engerix-B and Havrix for "revaccination". The number of previous injections of Engerix-B and Havrix were not specified. On 9/28/01, the pt was seen in the physician''s office and in the ER. He was hospitalized with a dx of second nerve bilateral optic papillitis. As of 10/3/01, the event was ongoing. F/U states the vaccine provider submitted this report directly to VAERS. The pt received Hep-A on 12/14/98 and 6/14/99. On 8/31/01, the pt received injections of Havrix and Engerix-B. On 9/28/01, the pt received his 2nd injection of Engerix-B. As he drove home from the MD''s office, he noticed greyness of vision at the inferior field of the left eye when he covered his right eye. On 10/2/01, he was seen by an ophthalmologist, who made a dx of bilateral papillitis, left greater than right. The pt was sent to the ER for further evaluation and was hospitalized. On admission, the pt reported that he had noted transient dizziness, lightheadedness and blurry vision while exercising 1 week prior to admission; these events resolved after several minutes. He also reported "some ill-defined mild decrease in concentration skills and general fatigue up recently. The dizziness, lightheadedness, blurry vision, decreased concentration and fatigue were not reported by the MD as symptoms of papillitis; the physician recorded the onset of papillitis as 9/28/01 PM. The pt recorded that he had no fever, focal weakness, dysesthesias, urine or stool incontinence, headache, stiff neck, dysphagia, nausea, vomiting or seizure-like activity. The pt was treated with acyclovir, ceftriaxone and acetylsalicylic acid 325mg daily. He received levofloxacin (Levaquin) 500mg daily for an unspecified number of days; it was discontinued 4 days after discharge from the hospital when Bartonella henselea serologies were reported as negative. He also received 1 injection of benzathine penicillin 2.4 million units; this was "not re-administered given the negative peripheral syphilis serologies". During the hospitalization, the visual acuity in the left eye decreased from 20/20 to 20/60. "He had no fevers, no headaches and no other visual changes during his stay". The pt was discharged to home in stable condition on 10/6/01. Discharge dx was "Bilateral papillitis, left greater that right". In the submission to VAERS, the vaccine provider reported the dx as "Bilateral optic neuritis thought to be vaccine associated". The most recent information was received on 10/22/01. The physician reported that the pt was seen as an outpt on 10/12/01. At that time, the pt "noted some very minor improvement in visual acuity". The physician stated, "no further specific treatment or testing was warranted at that time". The pt remained under the care of an ophthalmologist and the PCP. There were no known adverse experiences following receipt of prior immunizations and no known illnesses at the time of immunizations.


VAERS ID: 176978 (history)  
Form: Version 1.0  
Age:   
Sex: Female  
Location: Unknown  
Vaccinated:2001-03-20
Onset:2001-06-01
   Days after vaccination:73
Submitted: 2001-10-29
   Days after onset:150
Entered: 2001-11-01
   Days after submission:3
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEP: HEP B (RECOMBIVAX HB) / MERCK & CO. INC. - / 2 - / IM
HEPA: HEP A (VAQTA) / MERCK & CO. INC. - / 2 - / IM

Administered by: Other       Purchased by: Other
Symptoms: Gallbladder disorder, Hepatic enzyme abnormal, Hepatomegaly, Jaundice, Liver disorder, Pyrexia
SMQs:, Liver related investigations, signs and symptoms (narrow), Cholestasis and jaundice of hepatic origin (narrow), Hepatic failure, fibrosis and cirrhosis and other liver damage-related conditions (narrow), Acute pancreatitis (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Biliary system related investigations, signs and symptoms (narrow), Gallbladder related disorders (narrow), Biliary tract disorders (narrow), Cardiomyopathy (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? Yes
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: UNK
Allergies:
Diagnostic Lab Data: Hepatic function tests on 6/1/01-increased
CDC Split Type: WAES01103328

Write-up: Information has been received from a consumer concerning her daughter who on 3/20/01 was vaccinated with a 2nd dose of Hep-B vaccine recombinant (yeast). The mother reported that "within months" of vaccination, her daughter "developed a liver condition". It was noted that the pt experienced "increased liver enzyme levels, jaundice, fever and an enlarged and inflamed liver". Her gall bladder was removed because it "shut down". It was noted that the pt had been hospitalized several times. It was reported that the caller did not know the name of the vaccine and did not know if it was Hep-A or Hep-B. The caller was very difficult, threatened legal action, and refused to provide demographics. She disconnected the call before a legal address was able to be obtained. No further information is available.


VAERS ID: 177302 (history)  
Form: Version 1.0  
Age: 4.0  
Sex: Female  
Location: California  
Vaccinated:2001-03-28
Onset:2001-04-05
   Days after vaccination:8
Submitted: 2001-11-01
   Days after onset:210
Entered: 2001-11-07
   Days after submission:6
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (TRIPEDIA) / SANOFI PASTEUR UO341BA / 5 RL / IM
HEPA: HEP A (VAQTA) / MERCK & CO. INC. 1689K / 1 RL / IM
PNC: PNEUMO (PREVNAR) / PFIZER/WYETH 474720 / 1 LL / IM

Administered by: Public       Purchased by: Other
Symptoms: Epistaxis, Eye haemorrhage, Gingival bleeding, Petechiae
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Gingival disorders (narrow), Retinal disorders (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 1 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: NONE
Allergies:
Diagnostic Lab Data: Blood work done on 4/7/01
CDC Split Type:

Write-up: The pt was covered in large bruises all over her body. She had a nose bleed and petechia all over her body including eye area and bleeding gums. She was treated in ER and then transferred to the hospital for an overnight stay and treated with IV and Renrho. Diagnosed with thrombocytopenia


VAERS ID: 177379 (history)  
Form: Version 1.0  
Age: 19.0  
Sex: Female  
Location: Ohio  
Vaccinated:2000-03-20
Onset:2000-05-01
   Days after vaccination:42
Submitted: 2001-12-13
   Days after onset:591
Entered: 2001-11-08
   Days after submission:35
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEP: HEP B (ENGERIX-B) / SMITHKLINE BEECHAM 3202A2 / 2 LA / IM
HEPA: HEP A (HAVRIX) / SMITHKLINE BEECHAM 576B9 / 1 LA / IM

Administered by: Private       Purchased by: Other
Symptoms: Abdominal pain upper, Blood bilirubin increased, Dehydration, Liver disorder
SMQs:, Liver related investigations, signs and symptoms (narrow), Hepatic failure, fibrosis and cirrhosis and other liver damage-related conditions (narrow), Acute pancreatitis (narrow), Hyperglycaemia/new onset diabetes mellitus (broad), Biliary system related investigations, signs and symptoms (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Dehydration (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Actigall (ursodiol); Advil (ibuprofen); Depo-Provera (medroxyprogesterone A)
Current Illness:
Preexisting Conditions: Asthma; Gallbladder removal (11/00); polycystic ovary syndrome
Allergies:
Diagnostic Lab Data: A liver biopsy was performed and the mother reported that the pt "had inflammation of her liver with changes in the tissue but not the structure".
CDC Split Type: 2001026149

Write-up: The pt received her 1st injection of Engerix-B on an unspecified date; she had no adverse experience following receipt of this injection. She received her 2nd injection of Engerix-B and her 1st injection of Havrix on 3/20/00. An unspecified time, post vax, the pt was hospitalized due to pain in her liver, "her bilirubin being so high", and dehydration. The physician reportedly stated, "her liver is that of a geriatric pt". As of 10/23/01, the inflammation of the liver persisted. The outcome of the dehydration was not specified. The most recent info was received on 12/3/01. The pt''s mother reported that the pt had been "really, really ill" and had been "in the hospital five out fo the last ten days." The mother reported that the pt''s physicians "say there is no relationship" between the vaccines administered and the inflammation of the liver.


VAERS ID: 177717 (history)  
Form: Version 1.0  
Age: 52.0  
Sex: Female  
Location: Maine  
Vaccinated:1999-10-01
Onset:1999-12-01
   Days after vaccination:61
Submitted: 0000-00-00
Entered: 2001-11-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEP: HEP B (NO BRAND NAME) / UNKNOWN MANUFACTURER - / 2 - / IM
HEPA: HEP A (NO BRAND NAME) / UNKNOWN MANUFACTURER - / 2 - / IM

Administered by: Private       Purchased by: Private
Symptoms: Alopecia, Fatigue, Fibromyalgia, Immunoglobulins increased, Laboratory test abnormal, Thyroiditis, Vasculitis
SMQs:, Hypothyroidism (broad), Hyperthyroidism (broad), Vasculitis (narrow), Hypersensitivity (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: NONE
Preexisting Conditions: NONE
Allergies:
Diagnostic Lab Data: CRP 9.2; IgG and IgM levels increased
CDC Split Type:

Write-up: Alopecia, fibromyalgia, chronic fatigue, thyroiditis, vasculitis. Other vaccines given were Hep B 6/99 and Tetanus 5/99 unknown manufacturer/lot number. Per 1 year follow up: Pt did not recover. Symptoms all described in earlier VAERS submission.


VAERS ID: 177966 (history)  
Form: Version 1.0  
Age:   
Sex: Female  
Location: Utah  
Vaccinated:0000-00-00
Onset:2001-11-02
Submitted: 2001-11-15
   Days after onset:13
Entered: 2001-11-20
   Days after submission:5
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEPA: HEP A (VAQTA) / MERCK & CO. INC. - / UNK - / IM

Administered by: Other       Purchased by: Other
Symptoms: Convulsion, Pyrexia, Vomiting
SMQs:, Acute pancreatitis (broad), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad), Convulsions (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Generalised convulsive seizures following immunisation (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: NONE
Current Illness:
Preexisting Conditions: NONE
Allergies:
Diagnostic Lab Data: Temperature measurement-102F
CDC Split Type: WAES01110340

Write-up: Information has been received from an aunt of a female consumer who on an unspecified date was vaccinated with hepatitis A virus vaccine inactivated. Subsequently, the pt vomited for 2 days straight and experienced a fever of 102F. The child was treated with promethazine hydrochloride (Phenergan) which stopped the vomiting. On 11/2/01, the pt experienced a seizure. The child was hospitalized for the events. It was reported that the child had "several more" seizures while in the hospital. The events were considered to be immediately life-threatening. At the time of this report, the outcome of the fever and seizure was unknown. Additional information has been requested.


VAERS ID: 177967 (history)  
Form: Version 1.0  
Age: 13.0  
Sex: Female  
Location: California  
Vaccinated:2001-09-17
Onset:2001-09-17
   Days after vaccination:0
Submitted: 2001-11-16
   Days after onset:60
Entered: 2001-11-20
   Days after submission:4
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEPA: HEP A (VAQTA) / MERCK & CO. INC. 0687L / 1 LA / IM

Administered by: Private       Purchased by: Other
Symptoms: Abdominal pain, Gastrointestinal disorder, Pyrexia
SMQs:, Acute pancreatitis (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Retroperitoneal fibrosis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 6 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: NONE
Current Illness:
Preexisting Conditions: NONE
Allergies:
Diagnostic Lab Data: Pathological exam-acute appendicitis; Temperature measurement-101F
CDC Split Type: WAES01092009

Write-up: Information has been received from a consumer concerning his 13 year old daughter who on 9/17/01 at 14:30 (also reported as 15:30) was vaccinated with a 1st dose (lot 639764/0587L) IM in the left arm of hepatitis A virus vaccine inactivated. On 9/17/01, at 22:30, the pt was taken to the hospital with a fever of 101F and stomach cramps (it was also reported that the abdominal pain began in the morning of 9/18/01). Follow-up information received from a physician indicated that the pt underwent an appendectomy on 9/18/01 and symptoms resolved. It was noted that the pt''s abdominal pain was secondary to the appendicitis. A pathological exam on 9/19/01 dx''d the pt with an "acute appendicitis with early fibrinopurulent periappendicitis" that was "negative for malignancy". The pt was hospitalized for 6 days. The physician felt that the abdominal pain and the appendicitis were not related to the therapy with hepatitis A virus vaccine inactivated. No further info is available.


VAERS ID: 177972 (history)  
Form: Version 1.0  
Age: 16.0  
Sex: Female  
Location: California  
Vaccinated:2001-10-29
Onset:2001-11-07
   Days after vaccination:9
Submitted: 2001-11-16
   Days after onset:9
Entered: 2001-11-20
   Days after submission:4
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEPA: HEP A (VAQTA) / MERCK & CO. INC. 0686L / 1 LA / IM

Administered by: Other       Purchased by: Other
Symptoms: Blood creatine phosphokinase increased, Unevaluable event
SMQs:, Rhabdomyolysis/myopathy (broad), Neuroleptic malignant syndrome (broad), Myocardial infarction (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 4 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Aventis PPD (Mantoux) subcutaneous right forearm
Current Illness: NONE
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: CPK 677
CDC Split Type:

Write-up: Pt developed polymyositis with weakness which began 11/7/01. Follow up letter from reporter dated 11/16/2001 states that "After further investigating the PCP discover that this pt was not experiencing adverse event onset due to Hep A. VAERS was notified immediately."


VAERS ID: 178689 (history)  
Form: Version 1.0  
Age: 18.0  
Sex: Male  
Location: South Carolina  
Vaccinated:2001-11-26
Onset:2001-11-26
   Days after vaccination:0
Submitted: 2001-11-26
   Days after onset:0
Entered: 2001-12-06
   Days after submission:10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEPA: HEP A (VAQTA) / MERCK & CO. INC. 071L / UNK LA / IM
IPV: POLIO VIRUS, INACT. (POLIOVAX) / SANOFI PASTEUR T1189 / UNK RA / IM
YF: YELLOW FEVER (YF-VAX) / CONNAUGHT LABORATORIES UB127AA / UNK LA / SC

Administered by: Military       Purchased by: Military
Symptoms: Asthenia, Chest discomfort, Dyspnoea, Wheezing
SMQs:, Anaphylactic reaction (broad), Angioedema (broad), Asthma/bronchospasm (broad), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Guillain-Barre syndrome (broad), Cardiomyopathy (broad), Eosinophilic pneumonia (broad), Hypersensitivity (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: NONE
Preexisting Conditions: NONE
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Tightness in chest, SOB, wheezing and weakness after more than 20 minutes from receiving immunizations. Pt treated with SQ Epi, Solu medrol 125 and Benadryl 50 mg IV and Albuterol med treatment for 3 days.


VAERS ID: 180030 (history)  
Form: Version 1.0  
Age: 44.0  
Sex: Male  
Location: Texas  
Vaccinated:2001-08-06
Onset:2001-08-06
   Days after vaccination:0
Submitted: 2001-12-29
   Days after onset:145
Entered: 2002-01-16
   Days after submission:18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEP: HEP B (ENGERIX-B) / GLAXOSMITHKLINE BIOLOGICALS 5235A4 / 2 - / -
HEPA: HEP A (HAVRIX) / GLAXOSMITHKLINE BIOLOGICALS 698D6 / 2 - / -

Administered by: Private       Purchased by: Private
Symptoms: Blindness, Eye oedema, Eye pain, Headache, Memory impairment, Optic neuritis, Photophobia, Vision blurred
SMQs:, Anaphylactic reaction (broad), Angioedema (narrow), Anticholinergic syndrome (broad), Dementia (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (narrow), Glaucoma (broad), Optic nerve disorders (narrow), Demyelination (narrow), Lens disorders (broad), Corneal disorders (broad), Retinal disorders (broad), Depression (excl suicide and self injury) (broad), Ocular infections (broad), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Prilosec
Current Illness: NONE
Preexisting Conditions: Asthma; PCN allergy; GERD; Allergic rhinitis
Allergies:
Diagnostic Lab Data: Blood work; office exams; MRI
CDC Split Type:

Write-up: From 8/6/01 to 8/7/01, had a dull headache; took Tylenol Sinus & Allergy pills. On 8/8/01, had a feeling of pressure above right eye and a headache. On 8/9/01, had a loss of vision in eye; dx of optic neuritis; over the next 3 weeks, loss of colors, blurring, could not look at bright light and could not see some light (ex. car headlights); pain in eye, swelling. No treatment. From 10/01 to 11/01, began to return; reduction of pain, light flashes. In 12/01, sight is better but not the same (est. 85-90% normal). Also, in August, September and October 2001, had some memory difficulty. Annual follow up states patient has permanent deterioration of right optic nerve, right eye; continued visual problems in right the right eye.


Result pages: prev   6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=15&VAX[]=HEPA&VAX[]=HEPAB&VAX[]=HEPATYP&SERIOUS=ON


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166